Literature DB >> 3812627

International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease.

E Bloch-Michel, R B Nussenblatt.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3812627     DOI： 10.1016/s0002-9394(14)74235-7

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  167 in total

1.  Soluble ICAM-1 serum levels in patients with intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

2.  Is granuloma annulare related to intermediate uveitis with retinal vasculitis?

Authors:  B van Kooij; M Canninga van Dijk; J de Boer; V Sigurdsson; A Rothova
Journal:  Br J Ophthalmol       Date:  2003-06       Impact factor: 4.638

3.  Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis.

Authors:  R S Grajewski; A C Boelke; W Adler; S Meyer; A Caramoy; B Kirchhof; C Cursiefen; L M Heindl
Journal:  Eye (Lond)       Date:  2016-07-08       Impact factor: 3.775

4.  [Vision-threatening complications in childhood uveitis].

Authors:  A Mingels; T Hudde; C Heinz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2005-05       Impact factor: 1.059

5.  Alpha tropomyosin as a self-antigen in patients with Behçet's disease.

Authors:  S P Mahesh; Zhuqing Li; R Buggage; F Mor; I R Cohen; E Y Chew; R B Nussenblatt
Journal:  Clin Exp Immunol       Date:  2005-05       Impact factor: 4.330

6.  Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.

Authors:  John H Kempen; Mark L Van Natta; Michael M Altaweel; James P Dunn; Douglas A Jabs; Susan L Lightman; Jennifer E Thorne; Janet T Holbrook
Journal:  Am J Ophthalmol       Date:  2015-09-18       Impact factor: 5.258

7.  Neurotological status in Behçet's disease and its ophthalmological correlates.

Authors:  Y A Bayazit; C Evereklioğlu; E Ozer; N Kirtak; N Bayazit; M Kanlikama; S Inalöz
Journal:  Postgrad Med J       Date:  2004-12       Impact factor: 2.401

8.  Hypopyon in patients with uveitis.

Authors:  Ali A Zaidi; Gui-Shuang Ying; Ebenezer Daniel; Sapna Gangaputra; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne; C Stephen Foster; Douglas A Jabs; Grace A Levy-Clarke; Robert B Nussenblatt; John H Kempen
Journal:  Ophthalmology       Date:  2009-12-14       Impact factor: 12.079

Review 9.  Biologic agents in experimental autoimmune uveitis.

Authors:  Gian Paolo Giuliari; Ama Sadaka; David M Hinkle
Journal:  Int Ophthalmol       Date:  2013-03-14       Impact factor: 2.031

10.  Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis.

Authors:  A M Klok; L Luyendijk; M J Zaal; A Rothova; C E Hack; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.